GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Novo Integrated Sciences Inc (NAS:NVOS) » Definitions » E10

Novo Integrated Sciences (Novo Integrated Sciences) E10 : $-5.38 (As of Feb. 2024)


View and export this data going back to 2005. Start your Free Trial

What is Novo Integrated Sciences E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Novo Integrated Sciences's adjusted earnings per share data for the three months ended in Feb. 2024 was $-0.160. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is $-5.38 for the trailing ten years ended in Feb. 2024.

During the past 3 years, the average E10 Growth Rate was 41.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Novo Integrated Sciences was 45.70% per year. The lowest was 15.50% per year. And the median was 36.40% per year.

As of today (2024-05-22), Novo Integrated Sciences's current stock price is $0.47735. Novo Integrated Sciences's E10 for the quarter that ended in Feb. 2024 was $-5.38. Novo Integrated Sciences's Shiller PE Ratio of today is .


Novo Integrated Sciences E10 Historical Data

The historical data trend for Novo Integrated Sciences's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Novo Integrated Sciences E10 Chart

Novo Integrated Sciences Annual Data
Trend Dec14 Dec15 Dec16 Aug17 Aug18 Aug19 Aug20 Aug21 Aug22 Aug23
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only -53.02 -28.03 -16.38 -8.47 -5.75

Novo Integrated Sciences Quarterly Data
May19 Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -7.28 -6.44 -5.75 -5.51 -5.38

Competitive Comparison of Novo Integrated Sciences's E10

For the Medical Care Facilities subindustry, Novo Integrated Sciences's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Novo Integrated Sciences's Shiller PE Ratio Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Novo Integrated Sciences's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Novo Integrated Sciences's Shiller PE Ratio falls into.



Novo Integrated Sciences E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Novo Integrated Sciences's adjusted earnings per share data for the three months ended in Feb. 2024 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Feb. 2024 (Change)*Current CPI (Feb. 2024)
=-0.16/130.9299*130.9299
=-0.160

Current CPI (Feb. 2024) = 130.9299.

Novo Integrated Sciences Quarterly Data

per share eps CPI Adj_EPS
201403 -1.071 99.695 -1.407
201406 -2.000 100.560 -2.604
201409 -1.000 100.428 -1.304
201412 -2.000 99.070 -2.643
201503 -13.000 99.621 -17.086
201506 -2.000 100.684 -2.601
201509 -0.061 100.392 -0.080
201512 0.000 99.792 0.000
201603 -0.308 100.470 -0.401
201606 -0.076 101.688 -0.098
201609 -0.166 101.861 -0.213
201612 0.000 101.863 0.000
201703 -0.163 102.862 -0.207
201708 -0.149 103.587 -0.188
201711 -0.177 104.072 -0.223
201802 -1.000 105.052 -1.246
201805 -0.101 106.148 -0.125
201808 0.000 106.383 0.000
201811 -0.121 106.338 -0.149
201902 -0.056 106.649 -0.069
201905 -0.044 108.048 -0.053
201908 0.038 108.245 0.046
201911 -0.039 108.519 -0.047
202002 -0.200 109.139 -0.240
202005 -0.042 108.175 -0.051
202008 -1.800 109.662 -2.149
202011 -0.300 109.793 -0.358
202102 -0.600 110.968 -0.708
202105 -0.200 113.576 -0.231
202108 -0.800 115.421 -0.907
202111 -0.700 117.269 -0.782
202202 -1.700 119.703 -1.859
202205 -1.300 123.323 -1.380
202208 -7.580 124.958 -7.942
202211 -1.160 125.607 -1.209
202302 -0.590 126.928 -0.609
202305 -0.100 128.314 -0.102
202308 -0.100 129.538 -0.101
202311 -0.280 129.548 -0.283
202402 -0.160 130.930 -0.160

Add all the adjusted EPS together and divide 10 will get our e10.


Novo Integrated Sciences  (NAS:NVOS) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Novo Integrated Sciences E10 Related Terms

Thank you for viewing the detailed overview of Novo Integrated Sciences's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


Novo Integrated Sciences (Novo Integrated Sciences) Business Description

Traded in Other Exchanges
N/A
Address
11120 NE 2nd Street, Suite 100, Bellevue, WA, USA, 98004
Novo Integrated Sciences Inc is a medical care company. It provides specialized physiotherapy, chiropractic care, occupational therapy, eldercare, laser therapeutics, massage therapy, acupuncture, neurological functions, kinesiology, and others. It has two reportable segments: healthcare services which generates majority of the revenue, and product sales.
Executives
Sarfaraz Ali director C/O NOVO INTEGRATED SCIENCES, INC.,, 11120 NE 2ND STREET, SUITE 100, BELLEVUE WA 98004
Robert Letterio Oliva director 115 BELFIELD RD, TORONTO A6 L0J 1C0
Sterling M. Jimenez officer: Principal Financial Officer C/O NOVO INTEGRATED SCIENCES, INC.,, 11120 NE 2ND STREET, SUITE 100, BELLEVUE WA 98004
Michael Ross Pope director 1045 PROGRESS CIRCLE, LAWRENCEVILLE, GEORGIA GA 30043
Alex Flesias director 41 LANDMARK COURT, UNIONVILLE A6 L3R 9N7
Michael Joseph Gaynor director 49 BALMORAL ST, KEMPTVILLE A6 K0G 1J0
Robert Mattacchione director, 10 percent owner, officer: Chief Executive Officer 79 SELVAPIANO CRES, WOODBRIDGE A6 L4H 0X1
Pierre Joseph Dalcourt director, 10 percent owner 35 BRYANT ST , BOX 2230, HEARST A6 P0L 1N0
Christopher Mehlin David director, officer: President 10425 SE 22ND ST., BELLEVUE WA 98004
Thomas Edward Bray officer: Principal Financial Officer C/O NOVO INTEGRATED SCIENCES, INC., 11120 NE 2ND STREET, SUITE 100, BELLEVUE WA 98004
Rebecca Aw Mcdonald officer: Chief Accounting Officer 1301 INTERNATIONAL SPEEDWAY BLVD., DELAND FL 32724
James Jr Teters director 1200 FLIGHTLINE BLVD, STE 5, DELAN FL 32724
Phyllis Rouse officer: secretary 1200 FLIGHLINE BLVD,, SUITE 5, DELAND FL 32724
Jay Hilden officer: President & CEO 1200 FLIGHLINE BLVD,, SUITE 5, DELAND FL 32724
Robert Adamo director 1200 FLIGHTLINE BOULEVARD, SUITE 5, DELAND FL 32724